Bio-Rad Laboratories Revenue 2006-2019 | BIO

Bio-Rad Laboratories annual/quarterly revenue history and growth rate from 2006 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Bio-Rad Laboratories revenue for the quarter ending June 30, 2019 was $0.573B, a 0.57% decline year-over-year.
  • Bio-Rad Laboratories revenue for the twelve months ending June 30, 2019 was $2.289B, a 0.25% increase year-over-year.
  • Bio-Rad Laboratories annual revenue for 2018 was $2.289B, a 5.98% increase from 2017.
  • Bio-Rad Laboratories annual revenue for 2017 was $2.16B, a 4.45% increase from 2016.
  • Bio-Rad Laboratories annual revenue for 2016 was $2.068B, a 2.41% increase from 2015.
Bio-Rad Laboratories Annual Revenue
(Millions of US $)
2018 $2,289
2017 $2,160
2016 $2,068
2015 $2,019
2014 $2,175
2013 $2,133
2012 $2,069
2011 $2,074
2010 $1,927
2009 $1,784
2008 $1,764
2007 $1,461
2006 $1,274
2005 $1,181
Bio-Rad Laboratories Quarterly Revenue
(Millions of US $)
Q2 2019 $573
Q1 2019 $554
Q4 2018 $617
Q3 2018 $545
Q2 2018 $576
Q1 2018 $552
Q4 2017 $621
Q3 2017 $534
Q2 2017 $505
Q1 2017 $500
Q4 2016 $571
Q3 2016 $509
Q2 2016 $517
Q1 2016 $471
Q4 2015 $571
Q3 2015 $470
Q2 2015 $506
Q1 2015 $473
Q4 2014 $598
Q3 2014 $531
Q2 2014 $537
Q1 2014 $509
Q4 2013 $603
Q3 2013 $505
Q2 2013 $525
Q1 2013 $500
Q4 2012 $574
Q3 2012 $499
Q2 2012 $510
Q1 2012 $486
Q4 2011 $550
Q3 2011 $517
Q2 2011 $522
Q1 2011 $485
Q4 2010 $534
Q3 2010 $472
Q2 2010 $468
Q1 2010 $454
Q4 2009 $495
Q3 2009 $461
Q2 2009 $427
Q1 2009 $401
Q4 2008 $448
Q3 2008 $442
Q2 2008 $452
Q1 2008 $422
Q4 2007 $460
Q3 2007 $340
Q2 2007 $339
Q1 2007 $323
Q4 2006 $343
Q3 2006 $305
Q2 2006 $318
Q1 2006 $308
Q4 2005 $307
Q3 2005 $283
Q2 2005 $291
Q1 2005 $299
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $10.190B $2.290B
Bio-Rad Laboratories, Inc., together with its subsidiaries, engages in the manufacture and supply of products and systems for the life science research, healthcare, analytical chemistry, and other markets worldwide. The company's products are used to separate complex chemical and biological materials, and to identify, analyze, and purify their components. It operates in two segments, Life Science and Clinical Diagnostics. The Life Science segment offers electrophoresis, image analysis, molecular detection, chromatography, gene transfer, sample preparation, and amplification products and services. The Clinical Diagnostics segment provides control, autoimmune, diabetes, and blood virus testing products. Bio-Rad is renowned worldwide among hospitals, universities, major research institutions, as well as biotechnology and pharmaceutical companies for its commitment to quality and customer service. The company is headquartered in Hercules, California.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $149.115B 28.03
Medtronic (MDT) Ireland $144.617B 20.31
Stryker (SYK) United States $81.656B 28.24
Boston Scientific (BSX) United States $59.466B 28.84
Baxter (BAX) United States $44.526B 27.00
EssilorLuxottica Societe Anonyme (ESLOY) France $31.586B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.151B 18.02
Coloplast (CLPBY) Denmark $26.697B 42.62
Lonza Group Ag (LZAGY) Switzerland $26.607B 0.00
Terumo (TRUMY) Japan $23.560B 27.09
Smith & Nephew SNATS (SNN) United Kingdom $20.735B 0.00
ResMed (RMD) United States $19.545B 37.27
Sunny Optical Technology (SNPTF) China $14.643B 0.00
Insulet (PODD) United States $9.354B 554.25
Canopy Growth (CGC) Canada $8.712B 0.00
William Demant Holdings (WILYY) Denmark $7.136B 0.00
Hill-Rom Holdings (HRC) United States $7.062B 21.06
Haemonetics (HAE) United States $6.793B 51.26
Perrigo (PRGO) Ireland $6.499B 11.97
GN STORE NORD (GNNDY) Denmark $6.001B 30.65
Aurora Cannabis (ACB) Canada $5.891B 57.90
GW Pharmaceuticals (GWPH) United Kingdom $4.444B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
Neogen (NEOG) United States $3.753B 62.43
ICU Medical (ICUI) United States $3.439B 22.31
NuVasive (NUVA) United States $3.400B 27.10
Hutchison China MediTech (HCM) China $2.737B 0.00
Quidel (QDEL) United States $2.520B 25.02
Agios Pharmaceuticals (AGIO) United States $2.458B 0.00
National Vision Holdings (EYE) United States $2.257B 48.71
Cardiovascular Systems (CSII) United States $1.754B 0.00
Aphria (APHA) $1.634B 0.00
Phibro Animal Health (PAHC) United States $1.288B 19.30
AtriCure (ATRC) United States $1.035B 0.00
VAREX IMAGING (VREX) United States $1.028B 23.68
Omeros (OMER) United States $0.992B 0.00
PetIQ (PETQ) United States $0.900B 21.27
NanoString Technologies (NSTG) United States $0.896B 0.00
Lantheus Holdings (LNTH) United States $0.885B 23.25
Eagle Pharmaceuticals (EGRX) United States $0.796B 20.29
Cerus (CERS) United States $0.758B 0.00
MacroGenics (MGNX) United States $0.739B 0.00
Quanterix (QTRX) United States $0.667B 0.00
LeMaitre Vascular (LMAT) United States $0.624B 37.00
Surmodics (SRDX) United States $0.600B 114.08
TG Therapeutics (TGTX) United States $0.596B 0.00
OraSure Technologies (OSUR) United States $0.439B 20.34
Meridian Bioscience (VIVO) United States $0.410B 12.81
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.398B 0.00
BioLife Solutions (BLFS) United States $0.394B 129.63
United Health Products (UEEC) United States $0.374B 0.00
Utah Medical Products (UTMD) United States $0.346B 25.35
Zynex (ZYXI) United States $0.317B 33.65
Owens & Minor (OMI) United States $0.303B 9.09
Bovie Medical (APYX) United States $0.250B 0.00
Vapotherm (VAPO) United States $0.225B 0.00
Cytosorbents (CTSO) United States $0.160B 0.00
Fonar (FONR) United States $0.155B 8.16
Rockwell Medical (RMTI) United States $0.152B 0.00
Chimerix (CMRX) United States $0.144B 0.00
Female Health (VERU) United States $0.129B 0.00
InfuSystems Holdings (INFU) United States $0.098B 0.00
United-Guardian (UG) United States $0.089B 21.08
Chembio Diagnostics (CEMI) United States $0.087B 0.00
Surface Oncology (SURF) United States $0.057B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.056B 0.00
Nephros (NEPH) United States $0.053B 0.00
MRI INTERVENTNS (MRIC) United States $0.048B 0.00
ImmuCell (ICCC) United States $0.042B 0.00
Trinity Biotech (TRIB) Ireland $0.036B 0.00
Senestech (SNES) United States $0.028B 0.00
Myomo (MYO) United States $0.014B 0.00
Valeritas Holdings (VLRX) United States $0.012B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.010B 0.00
Capricor Therapeutics (CAPR) United States $0.010B 0.00
GUARDION HEALTH (GHSI) United States $0.009B 0.00
Akers Biosciences Inc (AKER) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00